Searched for
AJANTA PHARMA NEWS
Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...
- USFDA issues Form-483 with 5 observations to Ajanta Pharma's Paithan facilityAjanta Pharma said the US FDA has issued Form-483 with five observations after inspecting its Paithan manufacturing facility in Maharashtra...
- 5 mutual funds add 11 smallcap stocks to their portfolios in March. Check which onesFive mutual funds added 11 smallcap stocks to their portfolios in March, according to Nuvama Institutional Equities. SBI Mutual Fund and IC...
- Ajanta Pharma buyback: Last day today to buy shares for Rs 285 crore special situation opportunityAjanta Pharma has set May 30 as the record date for its Rs 285 crore share buyback,. The buyback, at a premium of 12.6%, targets 10,28,881 ...
- Ajanta Pharma’s Rs 285 crore share buyback can yield up to 6% return for retail investorsAjanta Pharma has fixed May 30 as the record date for its buyback of 0.82% of the aggregate paid-up share capital of the company at Rs 2,77...
- Ajanta Pharma shares jump over 13% on strong Q4 results, buyback plansAjanta Pharma shares jumped 13% to Rs 2,532 in Friday's trade on BSE after the firm's consolidated net profit increased 66% year-on-year (Y...
- Ajanta Pharma Q4 Results: Net profit soars 66% YoY to Rs 203 crRevenue from operations rose to Rs 1,054 crore in the fourth quarter of FY24 as compared with Rs 882 crore in the year-ago period, Ajanta P...
- Ajanta Pharma announces Rs 285 crore share buyback at 24% premiumAjanta Pharma on Thursday announced a Rs 285 crore buyback of up to 10.28 lakh shares through a tender offer at a price of Rs 2,770 — a pre...
- Buy Ajanta Pharma, target price Rs 2030: ICICI SecuritiesAjanta Pharma Ltd. key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue and Export Incentives for the yea...
- This smallcap pharma company declares 350% interim dividend; record date fixedPayment of interim dividend of Rs 7/- (350%) per equity share on the face-value of Rs 2/- per share for the Financial Year 2022-23,” said t...
- Buy Ajanta Pharma, target price Rs 1495: ICICI DirectAjanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 16369.91 Crore) operating in Pharmaceuti...
- Buy Ajanta Pharma, target price Rs 1495: ICICI DirectAjanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 16207.83 Crore) operating in Pharmaceuti...
- Hold Ajanta Pharma, target price Rs 1305: ICICI DirectAjanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 15564.46 Crore) operating in Pharmaceuti...
- Buy Ajanta Pharma, target price Rs 2080: Motilal OswalAjanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 13758.77 Crore) operating in Pharmaceuti...
- Buy Ajanta Pharma, target price Rs 2500: Motilal Oswal SecuritiesAjanta Pharma key Products/Revenue Segments include Pharmaceutical Products, Export Incentives and Other Operating Revenue for the year end...
- Ajanta Pharma Q2 results: Profit up 15% at Rs 196 croreRevenue from operations rose to Rs 885 crore in the second quarter as compared with Rs 716 crore in the year-ago period, Ajanta Pharma said...
- Buy Ajanta Pharma, target price Rs 1695: ICICI SecuritiesAjanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 13871.05 Crore) operating in Pharmaceuti...
Load More
